ONEMEDNET CORPORATION Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
ONEMEDNET CORPORATION (ONMD) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $358.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $358.00K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $233.00K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $585.00K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $149.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations as first filed |
|---|---|---|
| 2026-06-30 | $358.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $233.00K S-1/A · filed 2026-07-08 | |
| 2025-12-31 | $585.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $149.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $122.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $144.00K S-1/A · filed 2026-07-08 | |
| 2024-12-31 | $172.00K 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $1.93M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $707.00K 10-Q · filed 2025-08-13 | |
| 2024-03-31 | $174.00K 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $47.00K S-1/A · filed 2026-07-08 | $47.01K 10-K · filed 2024-04-09 |
| 2023-09-30 | $612.00K 10-Q · filed 2024-12-17 | $611.82K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $312.00K 10-Q · filed 2024-12-11 | |
| 2023-03-31 | $145.00K 10-Q · filed 2024-12-05 | |
| 2022-12-31 | $271.00K 10-K · filed 2025-04-15 | $270.86K 10-Q · filed 2023-11-20 |
| 2022-09-30 | $312.00K 8-K/A · filed 2024-11-22 | $312.33K 10-Q · filed 2023-11-20 |
| 2021-12-31 | $699.00K 8-K/A · filed 2024-11-22 | $699.32K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |